SCHEMBL308688

SCHEMBL308688

CCCCCCCCCCCC[N+](C)(C)CC(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.58
DNM1 Q05193 8/20 0.56
KMT2A Q03164 2/20 0.54
HSP90AA1 P07900 2/20 0.52
RAD52 P43351 2/20 0.52
PLA2G1B P04054 1/20 0.48
ATG4B Q9Y4P1 1/20 0.48
PPARG P37231 3/20 0.48
PPARD Q03181 3/20 0.48
PPARA Q07869 3/20 0.48
TSHR P16473 2/20 0.48
GPR84 Q9NQS5 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
ALDH1A1 P00352 1/20 0.48
SLC22A6 Q4U2R8 1/20 0.48
SLC22A8 Q8TCC7 1/20 0.48
TLR2 O60603 1/20 0.48
MEN1 O00255 1/20 0.48
ESR1 P03372 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14589612 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL8586568 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL8439979 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL901713 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL9917199 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL8438524 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL308046 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL1537860 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL8773947 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52
SCHEMBL14589610 1.00 HTT (0.58) HTTDNM1KMT2AHSP90AA1RAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1176 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3771337-B1 ANTIMICROBIAL COMPOSITION PROCTER & GAMBLE (US) 2026-04-29 EP claimed
US-20250270619-A1 COMPOSITIONS, KITS AND METHODS FOR DIRECT AMPLIFICATION FROM CRUDE BIOLOGICAL SAMPLES LIFE TECHNOLOGIES CORP (US) 2025-08-28 US claimed
US-20250052742-A1 NOVEL FORMULATION FOR DRYING OF POLYMER DYE CONJUGATED ANTIBODIES BECKMAN COULTER, INC. 2025-02-13 US claimed
US-20240376534-A1 MASTER MIX COMPOSITIONS, KITS, AND METHODS Life Technologies Corporation 2024-11-14 US claimed
EP-4430397-A1 NOVEL FORMULATION FOR DRYING OF POLYMER DYE CONJUGATED ANTIBODIES Beckman Coulter, Inc. (US) 2024-09-18 EP claimed
CN-112014338-B Paraoxonase-1 activity detection kit and application thereof 武汉生之源生物科技股份有限公司 2024-08-20 CN claimed
WO-2024160125-A1 DEGREASING AND DECOLORIZING COMPOSITION FOR NON-DEFORMATION TISSUE CLEARING AND USE THEREOF 清华大学 2024-08-08 WO claimed
CN-117903390-A Melamine resin-based amphiphilic collapse preventing agent and preparation method and application thereof 中国石油化工股份有限公司 2024-04-19 CN claimed
EP-4314350-A1 COMPOSITIONS, KITS, AND METHODS FOR VARIANT-RESISTANT DETECTION OF TARGET VIRAL SEQUENCES Life Technologies Corporation (US) 2024-02-07 EP claimed
US-20240016245-A1 ANTIMICROBIAL FACEMASK BMG (BRITISH MEDICAL GROUP) LIMITED (GB) 2024-01-18 US claimed
US-5335373-A Protective medical gloves and methods for their use DRESDNER JR KARL P (US) 1994-08-09 US claimed
EP-0532185-A2 Bleed alleviation using zwitterionic surfactants and cationic dyes Hewlett-Packard Company (US) 1993-03-17 EP claimed
EP-0526012-A2 Dye-set for polysaccharide-containing ink-jet printing inks Hewlett-Packard Company (US) 1993-02-03 EP claimed
EP-0526011-A1 High molecular weight colloids which control bleed Hewlett-Packard Company (US) 1993-02-03 EP claimed
EP-0509688-A1 Bleed alleviation in ink-jet inks Hewlett-Packard Company (US) 1992-10-21 EP claimed
US-5133803-A High molecular weight colloids which control bleed HEWLETT-PACKARD COMPANY (US) 1992-07-28 US claimed
US-5116409-A Bleed alleviation in ink-jet inks HEWLETT-PACKARD COMPANY (US) 1992-05-26 US claimed
US-5108504-A High chroma color dye-set for use in ink-jet inks employing polysaccharide-containing vehicles HEWLETT-PACKARD COMPANY (US) 1992-04-28 US claimed
US-5106416-A Using concentration of surfactant at which micelles form and attract dye molecules HEWLETT-PACKARD COMPANY (US) 1992-04-21 US claimed
EP-0475160-A1 Preparation for drug application in minute droplet form Cevc, Gregor, Prof. Dr. (DE) 1992-03-18 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016245-A1 ANTIMICROBIAL FACEMASK AMPD3, AMPD1, AMPD2 HTT 2922/4885DNM1 88/4885KMT2A 4417/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.